Call +44 (0)1904 798634 or +44 (0)7550 079918

Leading provider of life science market reports and research services

Contact Lenses - Medical Devices Pipeline Assessment, 2016

Be the first to review this product

Contact Lenses - Medical Devices Pipeline Assessment, 2016

Summary

GlobalData's Medical Devices sector report, 'Contact Lenses - Medical Devices Pipeline Assessment, 2016' provides an overview of...
You can choose to pay by purchase order during checkout

Availability: In stock

$4,000.00

* Required Fields

You can choose to pay by purchase order during checkout
GlobalData.

Digital downloads direct to your inbox within 24 hours.

First class customer service from our team of experts.

Pay by credit card or request an invoice

Product Description

Details

Contact Lenses - Medical Devices Pipeline Assessment, 2016

Summary

GlobalData's Medical Devices sector report, 'Contact Lenses - Medical Devices Pipeline Assessment, 2016' provides an overview of Contact Lenses currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Contact Lenses pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Contact Lenses under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Contact Lenses and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Contact Lenses under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product's current stage of development, territory and estimated launch date

Additional Information

Additional Information

Publisher name GlobalData.
Format PDF
Page count 172
Publication date 1 Apr 2016
Table of contents 1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 10
2 Introduction 11
2.1 Contact Lenses Overview 11
3 Products under Development 12
3.1 Contact Lenses - Pipeline Products by Stage of Development 12
3.2 Contact Lenses - Pipeline Products by Segment 13
3.3 Contact Lenses - Pipeline Products by Territory 14
3.4 Contact Lenses - Pipeline Products by Regulatory Path 15
3.5 Contact Lenses - Pipeline Products by Estimated Approval Date 16
3.6 Contact Lenses - Ongoing Clinical Trials 17
4 Contact Lenses - Pipeline Products under Development by Companies 18
4.1 Contact Lenses Companies - Pipeline Products by Stage of Development 18
4.2 Contact Lenses - Pipeline Products by Stage of Development 20
5 Contact Lenses Companies and Product Overview 23
5.1 Aeon Astron Corporation Company Overview 23
5.1.1 Aeon Astron Corporation Pipeline Products & Ongoing Clinical Trials Overview 23
5.2 Alcon, Inc. Company Overview 24
5.2.1 Alcon, Inc. Pipeline Products & Ongoing Clinical Trials Overview 24
5.3 Apeliotus Ophthalmics Company Overview 29
5.3.1 Apeliotus Ophthalmics Pipeline Products & Ongoing Clinical Trials Overview 29
5.4 Auburn University Company Overview 31
5.4.1 Auburn University Pipeline Products & Ongoing Clinical Trials Overview 31
5.5 Axcelon Biopolymers Corp. Company Overview 33
5.5.1 Axcelon Biopolymers Corp. Pipeline Products & Ongoing Clinical Trials Overview 33
5.6 Bausch & Lomb Incorporated Company Overview 34
5.6.1 Bausch & Lomb Incorporated Pipeline Products & Ongoing Clinical Trials Overview 34
5.7 Body Organ Biomedical Corp. Company Overview 38
5.7.1 Body Organ Biomedical Corp. Pipeline Products & Ongoing Clinical Trials Overview 38
5.8 Children's Hospital Boston Company Overview 40
5.8.1 Children's Hospital Boston Pipeline Products & Ongoing Clinical Trials Overview 40
5.9 CooperVision, Inc. Company Overview 42
5.9.1 CooperVision, Inc. Pipeline Products & Ongoing Clinical Trials Overview 42
5.10 EP Global Communications, Inc. Company Overview 43
5.10.1 EP Global Communications, Inc. Pipeline Products & Ongoing Clinical Trials Overview 43
5.11 Euclid Systems Corporation Company Overview 44
5.11.1 Euclid Systems Corporation Pipeline Products & Ongoing Clinical Trials Overview 44
5.12 Eyenovations Company Overview 45
5.12.1 Eyenovations Pipeline Products & Ongoing Clinical Trials Overview 45
5.13 EyeYon Medical Company Overview 46
5.13.1 EyeYon Medical Pipeline Products & Ongoing Clinical Trials Overview 46
5.14 Imperial College London Company Overview 49
5.14.1 Imperial College London Pipeline Products & Ongoing Clinical Trials Overview 49
5.15 Johnson & Johnson Vision Care, Inc. Company Overview 50
5.15.1 Johnson & Johnson Vision Care, Inc. Pipeline Products & Ongoing Clinical Trials Overview 50
5.16 Massachusetts Eye and Ear Infirmary Company Overview 54
5.16.1 Massachusetts Eye and Ear Infirmary Pipeline Products & Ongoing Clinical Trials Overview 54
5.17 Novartis AG Company Overview 56
5.17.1 Novartis AG Pipeline Products & Ongoing Clinical Trials Overview 56
5.18 Ocular Dynamics, LLC Company Overview 57
5.18.1 Ocular Dynamics, LLC Pipeline Products & Ongoing Clinical Trials Overview 57
5.19 Ocutec Limited Company Overview 58
5.19.1 Ocutec Limited Pipeline Products & Ongoing Clinical Trials Overview 58
5.20 Presbia Plc Company Overview 59
5.20.1 Presbia Plc Pipeline Products & Ongoing Clinical Trials Overview 59
5.21 Stanford University Company Overview 62
5.21.1 Stanford University Pipeline Products & Ongoing Clinical Trials Overview 62
5.22 The Hong Kong University of Science and Technology Company Overview 63
5.22.1 The Hong Kong University of Science and Technology Pipeline Products & Ongoing Clinical Trials Overview 63
5.23 The University of New South Wales Company Overview 64
5.23.1 The University of New South Wales Pipeline Products & Ongoing Clinical Trials Overview 64
5.24 UltraVision CLPL Company Overview 65
5.24.1 UltraVision CLPL Pipeline Products & Ongoing Clinical Trials Overview 65
5.25 University of California, San Diego Company Overview 66
5.25.1 University of California, San Diego Pipeline Products & Ongoing Clinical Trials Overview 66
5.26 University of Florida Company Overview 68
5.26.1 University of Florida Pipeline Products & Ongoing Clinical Trials Overview 68
5.27 University of Valencia Company Overview 69
5.27.1 University of Valencia Pipeline Products & Ongoing Clinical Trials Overview 69
5.28 University of Washington Company Overview 71
5.28.1 University of Washington Pipeline Products & Ongoing Clinical Trials Overview 71
5.29 University of Western Ontario Company Overview 74
5.29.1 University of Western Ontario Pipeline Products & Ongoing Clinical Trials Overview 74
5.30 Valeant Pharmaceuticals International, Inc. Company Overview 75
5.30.1 Valeant Pharmaceuticals International, Inc. Pipeline Products & Ongoing Clinical Trials Overview 75
5.31 Visioneering Technologies, Inc. Company Overview 95
5.31.1 Visioneering Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 95
5.32 VISTAKON Pharmaceuticals, LLC Company Overview 101
5.32.1 VISTAKON Pharmaceuticals, LLC Pipeline Products & Ongoing Clinical Trials Overview 101
5.33 Yolia Health Company Overview 102
5.33.1 Yolia Health Pipeline Products & Ongoing Clinical Trials Overview 102
6 Contact Lenses- Recent Developments 103
6.1 Mar 03, 2016: The Cooper Companies Announces First Quarter 2016 Results 103
6.2 Mar 01, 2016: First Patients in Presbia Microlens FDA Study Complete 12-Month Postoperative Visits 104
6.3 Feb 19, 2016: Strong growth in revenue and earnings Essilor focused on its 2018 objectives 104
6.4 Feb 12, 2016: Carl Zeiss Meditec Grows, Boosted by Currency Tailwinds / Strongest Growth Once Again in Surgical Ophthalmology 105
6.5 Feb 05, 2016: Briefing Summary of the Analyst/Investor Meeting for the 3rd Quarter Financial Results for the Fiscal Year Ending March 31, 2016 Tokyo, January 29, 2016 106
6.6 Jan 29, 2016: Hoya Reports Third Quarter Results; Record Nine Months Results 109
6.7 Jan 27, 2016: Novartis delivered strong sales growth and core margin expansion (cc[1]) in 2015; announces plans to accelerate growth at Alcon, streamline Group operations 110
6.8 Jan 15, 2016: HOYA Presents Hoya EyeGenius 119
6.9 Dec 16, 2015: AEA Investors to Acquire Majority Stake in 1-800 Contacts from Thomas H. Lee Partners 120
6.10 Dec 16, 2015: Carl Zeiss Meditec increases revenue to

Reviews

Write Your Own Review

Only registered users can write reviews. Please, log in or register

Product Tags

Product Tags

Use spaces to separate tags. Use single quotes (') for phrases.